1985
DOI: 10.1007/bf00214637
|View full text |Cite
|
Sign up to set email alerts
|

Neurochemically similar myenteric and submucous neurons directly traced to the mucosa of the small intestine

Abstract: Antisera to neuropeptide Y (NPY) gave an intense immunohistochemical reaction of certain nerve cells in the myenteric and submucous plexuses of the guinea-pig small intestine. Each nerve cell had up to 20 branching, tapering processes that were less than approximately 50 micron long and a long process that could be followed for a considerable distance. This morphology corresponds to that of the type-III cells of Dogiel. The long process of each myenteric cell ran through the circular muscle to the submucosa, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
75
1

Year Published

1987
1987
2007
2007

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 185 publications
(79 citation statements)
references
References 19 publications
3
75
1
Order By: Relevance
“…This is supported by the abolition of staining by preadsorption of 1.B3.9B3 with human placental ChAT and the lack of staining with an irrelevant, isotypematched monoclonal antibody (anti-hepatitis B surface antigen). The localization of ChAT IR in the submucosal and myenteric plexi is consistent with other reports that employed immunocytochemistry on whole mounts (Furness et al 1984(Furness et al ,1985Schemann et al 1993Schemann et al ,1995Mann et al 1995), including studies that successfully used 1.B3.9B3 (Schemann et al 1993(Schemann et al ,1995. In addition, ChAT IR and activity in endothelia of various tissues have been previously described (Parnavelas et al 1985;Gonzalez and Santos-Benito 1987;Milner et al 1989), and there are reports of ChAT in epithelial cells (Grando et al 1993;Sakuragawa et al 1997) and lymphocytes (Rinner and Schauenstein 1993).…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…This is supported by the abolition of staining by preadsorption of 1.B3.9B3 with human placental ChAT and the lack of staining with an irrelevant, isotypematched monoclonal antibody (anti-hepatitis B surface antigen). The localization of ChAT IR in the submucosal and myenteric plexi is consistent with other reports that employed immunocytochemistry on whole mounts (Furness et al 1984(Furness et al ,1985Schemann et al 1993Schemann et al ,1995Mann et al 1995), including studies that successfully used 1.B3.9B3 (Schemann et al 1993(Schemann et al ,1995. In addition, ChAT IR and activity in endothelia of various tissues have been previously described (Parnavelas et al 1985;Gonzalez and Santos-Benito 1987;Milner et al 1989), and there are reports of ChAT in epithelial cells (Grando et al 1993;Sakuragawa et al 1997) and lymphocytes (Rinner and Schauenstein 1993).…”
Section: Discussionsupporting
confidence: 88%
“…Reports using AChE histochemistry on normal mucosa either have dubious specificity (Isaacs et al 1976) or report few or no cholinergic nerve fibers (Lake et al 1978). Studies with ChAT immunohistochemistry on whole mounts have traced ChAT IR nerve processes to the mucosa but have not demonstrated ChAT IR nerve fibers in this compartment (Furness et al 1985). Possibly, ChAT is not transported into mucosal nerve processes, or a non-1.B3.9B3-immunoreactive ChAT isoenzyme is present in mucosal nerves (for a discussion of ChAT expression, see Mallet et al 1990).…”
Section: Figurementioning
confidence: 99%
See 1 more Smart Citation
“…Wholemounts, fixed and prepared as above, were incubated in primary antisera against NPY (sheep anti-NPY, E2210, 1:400 (Furness et al, 1985)). After the preparations were washed they were incubated with biotinylated donkey anti-sheep IgG, 1:200.…”
Section: Methodsmentioning
confidence: 99%
“…These four types include 1) neurons with immunoreactivity for vasoactive intestinal peptide (VIP) and several other peptides, including galanin, dynorphin, and neuromedin U; 2) neurons immunoreactive for neuropeptide Y (NPY), choline acetyltransferase (ChAT), somatostatin, and calcitonin gene-related peptide; 3) neurons immunoreactive for calretinin, ChAT, and dynorphin; and 4) neurons with a typical Dogiel type II morphology that are immunoreactive for ChAT and tachykinins, about half of which are also immunoreactive for calbindin. NPY immunoreactivity defines the shapes of one phenotype (Furness et al, 1985), but neither VIP nor calretinin, nor other markers of the VIP and calretinin phenotypes, reveal the dendritic morphologies of these types (Furness et al, 1984;Brookes et al, 1991).…”
mentioning
confidence: 96%